T1	HMM 726 797	safety profile, pharmacokinetics, immunogenicity, and clinical effects.
T2	HMM 833 847	adverse events
T3	HMM 924 966	drug-related hypotensive infusion reaction
T4	HMM 1152 1173	myocardial infarction
T5	HMM 1321 1330	half-life
T6	HMM 1421 1439	clinical activity.
